Pierce David A 4
4 · BOSTON SCIENTIFIC CORP · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Pierce David A
SVP and President, Endoscopy
Transactions
- Exercise/Conversion
Common Stock
2022-02-28+2,444→ 2,444 total - Tax Payment
Common Stock
2022-02-28$44.17/sh−718$31,714→ 1,726 total - Sale
Common Stock
2022-03-01$43.94/sh−1,726$75,840→ 0 total - Exercise/Conversion
Deferred Stock Units
2022-02-28−2,444→ 0 totalExp: 2022-02-28→ Common Stock (2,444 underlying)
Footnotes (3)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- [F3]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.